These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 24528892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
    Long W, Deng X, Zhang Y, Lu G, Xie J, Tang J.
    Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
    Kasamatsu Y, Yamaguchi T, Kawaguchi T, Tanaka N, Oka H, Nakamura T, Yamagami K, Yoshioka K, Imanishi M.
    Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH, Wee JH, Choi SP, Oh SH.
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [Abstract] [Full Text] [Related]

  • 9. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, Esteban C, Bereciartua E, Unanue U, Uranga A.
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM, Teixeira-Pinto A, Basílio C, Sousa-Dias C, Mergulhão P, Paiva JA.
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [Abstract] [Full Text] [Related]

  • 13. The role of procalcitonin in adult patients with community-acquired pneumonia--a systematic review.
    Berg P, Lindhardt BØ.
    Dan Med J; 2012 Mar; 59(3):A4357. PubMed ID: 22381083
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.
    Johansson N, Kalin M, Backman-Johansson C, Larsson A, Nilsson K, Hedlund J.
    Scand J Infect Dis; 2014 Nov; 46(11):787-91. PubMed ID: 25195651
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Procalcitonin kinetics in Legionella pneumophila pneumonia.
    de Jager CP, de Wit NC, Weers-Pothoff G, van der Poll T, Wever PC.
    Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.